Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Senti Biosciences Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Posted On Tuesday, July 22, 2025
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
Posted On Tuesday, July 22, 2025
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
Posted On Tuesday, July 22, 2025
Veru to Participate in the 2025 BTIG Virtual Biotech Conference
Posted On Tuesday, July 22, 2025
aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
Posted On Tuesday, July 22, 2025
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
Posted On Tuesday, July 22, 2025
Llusern Scientific Announces Key Appointments to Strengthen its Executive Team
Posted On Tuesday, July 22, 2025
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+
Posted On Tuesday, July 22, 2025
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies
Posted On Tuesday, July 22, 2025
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
Posted On Monday, July 21, 2025
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
Posted On Monday, July 21, 2025
PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
Posted On Monday, July 21, 2025
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
Posted On Monday, July 21, 2025
TELA Bio to Announce Second Quarter 2025 Financial Results
Posted On Monday, July 21, 2025
Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
Posted On Monday, July 21, 2025
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
Posted On Monday, July 21, 2025
Kaida BioPharma Chairman and Founding Investor, Craig Pierson, to Present at Opal Group’s Family Office & Private Wealth Management Forum 2025
Posted On Monday, July 21, 2025
Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum
Posted On Monday, July 21, 2025
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
Posted On Monday, July 21, 2025
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
Posted On Monday, July 21, 2025
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Posted On Monday, July 21, 2025
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
Posted On Monday, July 21, 2025
NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases
Posted On Monday, July 21, 2025
Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy
Posted On Monday, July 21, 2025
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
Posted On Monday, July 21, 2025

Print